ABOUT THIS SELECTION
The permanent record for Orakl Oncology identifies Rezo Zero as the credited studio and places the project in the Business category. Its recorded distinction is Nominee in January 2026. Related archive sections provide factual context through the same studio, year and recognition level.
Editorial record
Blended archive allocation